Catalyst Conference Call Series: Alnylam Pharmaceuticals (ALNY): TTR Amyloidosis, Porphyria, and the RNAi Platform

At B. Riley and Co., we offer unparalleled value, proprietary research, and creative banking solutions to our clients.

Catalyst Conference Call Series: Alnylam Pharmaceuticals (ALNY): TTR Amyloidosis, Porphyria, and the RNAi Platform

Catalyst Conference Call Series: Alnylam Pharmaceuticals (ALNY): TTR Amyloidosis, Porphyria, and the RNAi Platform

Catalyst Conference Call Series: Alnylam Pharmaceuticals (ALNY): TTR Amyloidosis, Porphyria, and the RNAi Platform

Quick Nav
Quick Nav
Research